Rekvina Laboratories share news, announcements and annual reports
BSE: 526075Pharmaceuticals & BiotechnologySmall Cap
Rekvina Laboratories Ltd · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Nov 1993
Last close ₹57.94down ₹2.72 (4.48%)
Share price at the BSE close on 28 Oct 2026. Previous close ₹60.66.
28 Oct: open ₹63.50, high ₹63.50, low ₹57.63
- Under BSE's graded surveillance, stage 0, on the list for 27 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹64 Cr4,235th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business.
- Net worth zero or below
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −139.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- Net worth zero or below
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 2,619
Rekvina Laboratories results
59 filed, newest first. Page 1 of 2.
Aug 2026
13 Aug · Results
13 Aug · Results
May 2026
Feb 2026
Nov 2025
14 Nov · Results
Aug 2025
13 Aug · Results
13 Aug · Results
May 2025
30 May · Results
Jan 2025
Nov 2024
May 2024
30 May · Results
Feb 2024
Aug 2023
May 2023
Nov 2022
Feb 2022
Jun 2021
23 Jun · Results
Feb 2021
16 Feb · Results
16 Feb · Results
Dec 2020
18 Dec · Results
Sep 2020
Sep 2019
Jan 2019
8 Jan · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Dec 2017
14 Dec · Results
Aug 2017
14 Aug · Results
May 2017
Feb 2017
Nov 2016
Oct 2016
Aug 2016
May 2016
Feb 2016
Nov 2015
Aug 2015
Jul 2015
Feb 2015
Dec 2014
Aug 2014
May 2014
Feb 2014
Dec 2013